Stocks · Health care · Biological Products, (No Diagnostic Substances)

RECURSION PHARMACEUTICALS, INC.

RXRX Clue Score60
United States Fiscal year ends December CIK 0001601830 Results filed 2 Nov 2026

What the insiders did Net buying

Nothing of that kind in this period.

What was left out

Form 4 filings counted 479
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 22
Sales on a Rule 10b5-1 plan 57
Sales straight out of an exercise 308
Sales at will 56
Transactions with no price 0
Shares from compensation/vesting 217,995,789
Sales filed before the plan box existed 31
History held since 19 Apr 2021